Academic Journal

Clinical-experimental data influence Speroton on the fertility parameters of ejaculate ; Клинико-экспериментальные данные влияния биологически активной добавки Сперотон на параметры фертильности эякулята

التفاصيل البيبلوغرافية
العنوان: Clinical-experimental data influence Speroton on the fertility parameters of ejaculate ; Клинико-экспериментальные данные влияния биологически активной добавки Сперотон на параметры фертильности эякулята
المؤلفون: O. B. Zhukov, V. V. Evdokimov, A. A. Zhukov, О. Б. Жуков, В. В. Евдокимов, А. А. Жуков
المصدر: Andrology and Genital Surgery; Том 16, № 2 (2015); 44-50 ; Андрология и генитальная хирургия; Том 16, № 2 (2015); 44-50 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2015-2
بيانات النشر: "PH "ABV-Press"", LLC
سنة النشر: 2015
المجموعة: Andrology and Genital Surgery (E-Journal) / Андрология и генитальная хирургия
مصطلحات موضوعية: активная подвижность сперматозоидов, fertility, ejaculate, idiopathic infertility, varicocele, assisted reproductive technologies, idiopathic patozoospermia, active sperm motility, фертильность, эякулят, идиопатическое бесплодие, варикоцеле, вспомогательные репродуктивные технологии, идиопатическая патозооспермия
الوصف: The article analyzes the experience of studying the properties of patients ejaculate. They were 30 men with normal semen, idiopathic infertility secretory type and varicocele in the postoperative period. The total number of patients was 30, 10 in each group. The study was conducted with dietary supplement Speroton (without the inclusion of ancillary components) to the maximum effective concentration. Stages of the study consisted of the evaluation of the main indicators of semen (WHO, 5th edition). The study was conducted over 30 minutes, 1 hour, 3 hours and 24 hours after the addition of the dietary supplement Speroton. Set material was 3 months. The study dietary supplement Speroton was used in three different concentrations (1:100,1:200,1:1000). Was used to estimate the mobility, viability and morphology of spermatozoa within a specified time of incubation by mixing the dietary supplement and ejaculate. The study of sperm motility in groups separated by disease, showed the following changes: the best results were in group 1 – active mobility increase by 46 % in the first hour of incubation, total – 15 % for the first hour of incubation. In second place were indicators of mobility in the third group after surgery for varicocele – 22 and 14 %, respectively, in last place in the group, with a secretory infertility is increasing the activity and overall mobility was 14 %. The study of the dietary supplement in the experiment revealed Speroton positive effect on sperm motility active. Maximum effect was obtained at a dilution of 1:200 – active mobility increased by 27 % for the 1st hour experiment. The results obtained allow to recommend the dietary supplement Speroton as part of precomplex conservative therapy in patients referred for treatment methods of assisted reproductive technologies, as well as in patients with a change in fertility due to varicocele in the postoperative period and idiopathic patozoospermia. ; В обзоре проанализировано изучение свойств эякулята 30 мужчин: с нормальными показателями ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: Russian
Relation: https://agx.abvpress.ru/jour/article/view/145/138; Сухих Г. Т., Божедомов В.А. Мужское бесплодие. М.: Эксмо, 2008. С. 239. [Sukhikh G.T., Bozhedomov V.A. Male infertility. Moscow: Eksmo, 2008. P. 239. (In Russ.)].; Рождаемость и планирование семьи в России. История и перспективы. Сборник статей «Демографические исследования». Под ред. И.А. Троицкой, А.А. Авдеева, М.: МГУ, 2011; 18; с. 177. [Birthrate and family planning in Russia. Background and prospects. Collected articles "Demography studies". I.A. Troitskaya, А.А. Avdeev (eds.).Moscow: Moscow State University, 2011; 18; p. 177. (In Russ.)].; Zini A., Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl 2011;13:1–9.; Vicari E., Calogero A.E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymis. Hum Reprod 2001;16(11):2338–42.; Micic S., Lalic N., Bojanic N., Nale D.J. Carnitine therapy of oligospermic men. 25th Annual Meeting program and abstracts, 7–11.05.2000. Boston: American Society of Andrology, 2000. P. 68.; Zini A., Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl 2011;13(3):374–81.; Брагина Е.Е., Арифулин Е.А., Бочарова Е.Н. Роль мужского фактора в нарушениях раннего эмбриогенеза. Материалы XXIV Международной конференции Российской ассоциации репродукции человека. Репродуктивные технологии сегодня и завтра (3–6 cентября 2014 г., Ярославль). С.107–8. [Bragina E.E., Arifullin E.A., Bocharova E.N. Role of male factor in early embryogenesis disorder. Materials of XXIV International Conference of Russian Association of Human Reproduction. Reproduction technologies of today and tomorrow (September 3–6, 2014, Yaroslavl). Pp. 107–8. (In Russ.)].; https://agx.abvpress.ru/jour/article/view/145
DOI: 10.17650/2070-9781-2015-16-2-44-50
الاتاحة: https://agx.abvpress.ru/jour/article/view/145
https://doi.org/10.17650/2070-9781-2015-16-2-44-50
Rights: Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие статьи в данном журнале, соглашаются на следующее:Авторы сохраняют за собой автороские права и предоставляют журналу право первой публикации работы, которая по истечении 6 месяцев после публикации автоматически лицензируется на условиях Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).
رقم الانضمام: edsbas.263FEF2C
قاعدة البيانات: BASE
الوصف
DOI:10.17650/2070-9781-2015-16-2-44-50